The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects - Top-Institutions - MDSpire

The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects

  • By

  • Subakathulla, Sumayyah

  • Manoj, Norwin

  • Patanwala, Azima Muzzammil

  • Premvignesh, Prasanna Appiya

  • Maher, Yamen

  • Majie, Ankit

  • Gorain, Bapi

  • Dutta, PhD, Sulagna

  • Sengupta, PhD, Pallav

  • Maldonado Rosas, Israel

  • Roychoudhury, Shubhadeep

  • April 9, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Reproductive Medicine
    • Metabolic Research

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Reproductive Endocrinology
    • Clinical Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Reproductive Medicine
    • Molecular Biology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Metabolic Disorders
    • Clinical Trials

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Reproductive Biology
    • Translational Medicine

Original Source(s)

The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects

  • by Subakathulla, Sumayyah , Manoj, Norwin , Patanwala, Azima Muzzammil, Premvignesh, Prasanna Appiya, Maher, Yamen , Majie, Ankit , Gorain, Bapi , Dutta, PhD, Sulagna , Sengupta, PhD, Pallav , Maldonado Rosas, Israel , Roychoudhury, Shubhadeep

  • April 9, 2026

Related Content

Follicular fluid proteomic alterations associated with oocyte developmental potential in polycystic ovary syndrome

Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome

  • June 5, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.